logo

For the Inventor, By the Inventor

Jersey City, NJ, United States of America

Michael J Zacuto

This inventor holds 12 USPTO granted patents. Top assignees: Merck Sharp + Dohme Corp., Celgene Corporation, Banyu Pharmaceutical Co. Ltd. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Zacuto. Retrieved from https://idiyas.com/inventor/michael-j-zacuto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 91.7

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal8 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal6 out of 561 
 
Celgene Corporation
 patents
bronzeMedal1 out of 237 
 
Banyu Pharmaceutical Co. Ltd
 patents
where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...
12 patents (USPTO):Explore Patents
1. 12577223 - Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (2026-03-17),
2. 12435028 - Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate (2025-10-07),
3. 11912644 - Processes for the preparation of ()-tert-butyl 4,5-diamino-5-oxopentanoate (2024-02-27),
4. 11505522 - Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate (2022-11-22),
5. 11312699 - Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (2022-04-26),
6. 10717703 - Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate (2020-07-21),
7. 10053466 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2018-08-21),
8. 9862725 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2018-01-09),
9. 9527855 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2016-12-27),
10. 9187488 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2015-11-17),
11. 9120818 - Process and intermediates for preparing macrolactams (2015-09-01),
12. 7902376 - Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates (2011-03-08),

Title: The Innovative Contributions of Michael J Zacuto

Introduction

Michael J Zacuto is a prominent inventor based in Jersey City, NJ (US), known for his significant contributions to the field of chemistry. With a total of 11 patents to his name, Zacuto has made remarkable advancements in the preparation of various chemical compounds.

Latest Patents

Among his latest patents are processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate. These patents provide detailed methodologies for creating (S)-tert-butyl 4,5-diamino-5-oxopentanoate, including its salts, solvates, hydrates, enantiomers, and isotopologues. Additionally, Zacuto has developed processes for the preparation of ()-tert-butyl 4,5-diamino-5-oxopentanoate, which also encompass solid forms of various intermediates and products derived from these processes.

Career Highlights

Zacuto has had a distinguished career, working with notable companies such as Merck Sharp & Dohme Corporation and Celgene Corporation. His experience in these leading pharmaceutical companies has allowed him to refine his expertise and contribute to groundbreaking innovations in the industry.

Collaborations

Throughout his career, Zacuto has collaborated with esteemed colleagues, including Weihong Zhang and Lushi Tan. These partnerships have fostered a collaborative environment that has led to the successful development of his patented processes.

Conclusion

Michael J Zacuto's innovative work in the field of chemistry, particularly in the preparation of complex compounds, showcases his dedication to advancing scientific knowledge. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…